ArticleScientific reports2025
Optimizing plasmonic photothermal therapy a numerical study on tissue specific thermal and optical properties for cancer treatment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Resonance Energy Transfer-Driven Photothermal Nanoagent Enables Melanoma Ablation Under Low-Power Near-Infrared Irradiation.Advanced functional materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Effective cancer treatment demands precision to target malignant tissues while sparing healthy ones. This study investigates numerically the role of plasmonic photothermal therapy (PPTT) as a minimally invasive approach to achieve this goal, focusing on the interplay between nanoparticle (NP) size, resonance wavelength, and the thermal properties of biological tissues. Tailoring NP characteristics to align with tissue-specific optical and thermal properties enables precise thermal delivery, enhancing therapeutic efficacy while minimizing collateral damage. Resonance wavelength shifts with NP size, while tissue parameters like thermal conductivity and refractive index further influence temperature profiles. These findings highlight the importance of optimizing PPTT protocols through computational modeling and experimental validation. This approach advances personalized cancer therapies, offering safer and more effective treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.